These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29172642)

  • 1. Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease.
    Persson K; Barca ML; Cavallin L; Brækhus A; Knapskog AB; Selbæk G; Engedal K
    Acta Radiol; 2018 Aug; 59(8):997-1001. PubMed ID: 29172642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Efficacy of Structural MRI in Patients With Mild-to-Moderate Alzheimer Disease: Automated Volumetric Assessment Versus Visual Assessment.
    Min J; Moon WJ; Jeon JY; Choi JW; Moon YS; Han SH
    AJR Am J Roentgenol; 2017 Mar; 208(3):617-623. PubMed ID: 28075620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease?
    Boutet C; Chupin M; Colliot O; Sarazin M; Mutlu G; Drier A; Pellot A; Dormont D; Lehéricy S;
    Neuroradiology; 2012 Dec; 54(12):1321-30. PubMed ID: 22782577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.
    Visser PJ; Verhey FR; Hofman PA; Scheltens P; Jolles J
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):491-7. PubMed ID: 11909909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional MRI volumetry using NeuroQuant versus visual rating scales in patients with cognitive impairment and dementia.
    Persson K; Barca ML; Edwin TH; Cavallin-Eklund L; Tangen GG; Rhodius-Meester HFM; Selbæk G; Knapskog AB; Engedal K
    Brain Behav; 2024 Feb; 14(2):e3397. PubMed ID: 38600026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without Alzheimer disease.
    Enache D; Cavallin L; Lindberg O; Farahmand B; Kramberger MG; Westman E; Jelic V; Eriksdotter M; Ballard C; Winblad B; Wahlund LO; Aarsland D
    J Geriatr Psychiatry Neurol; 2015 Mar; 28(1):40-8. PubMed ID: 25080472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully automated structural MRI of the brain in clinical dementia workup.
    Persson K; Selbæk G; Brækhus A; Beyer M; Barca M; Engedal K
    Acta Radiol; 2017 Jun; 58(6):740-747. PubMed ID: 27687251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population.
    Molinder A; Ziegelitz D; Maier SE; Eckerström C
    BMC Neurol; 2021 Jul; 21(1):289. PubMed ID: 34301202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.
    Burton EJ; Barber R; Mukaetova-Ladinska EB; Robson J; Perry RH; Jaros E; Kalaria RN; O'Brien JT
    Brain; 2009 Jan; 132(Pt 1):195-203. PubMed ID: 19022858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.
    Ten Kate M; Barkhof F; Boccardi M; Visser PJ; Jack CR; Lovblad KO; Frisoni GB; Scheltens P;
    Neurobiol Aging; 2017 Apr; 52():167-182.e1. PubMed ID: 28317647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer's disease diagnosis.
    Wittens MMJ; Allemeersch GJ; Sima DM; Vanderhasselt T; Raeymaeckers S; Fransen E; Smeets D; de Mey J; Bjerke M; Engelborghs S
    Neuroradiology; 2024 Apr; 66(4):487-506. PubMed ID: 38240767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between visual assessment of MTA and hippocampal volumes in an elderly, non-demented population.
    Cavallin L; Bronge L; Zhang Y; Oksengård AR; Wahlund LO; Fratiglioni L; Axelsson R
    Acta Radiol; 2012 Jun; 53(5):573-9. PubMed ID: 22593123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual assessment of medial temporal atrophy on MR films in Alzheimer's disease: comparison with volumetry.
    Bresciani L; Rossi R; Testa C; Geroldi C; Galluzzi S; Laakso MP; Beltramello A; Soininen H; Frisoni GB
    Aging Clin Exp Res; 2005 Feb; 17(1):8-13. PubMed ID: 15847116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population.
    Wei M; Shi J; Ni J; Zhang X; Li T; Chen Z; Zhou M; Zhang L; Tan Z; Wang Y; Tian J
    BMC Geriatr; 2019 Feb; 19(1):59. PubMed ID: 30819102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study.
    Wahlund LO; Julin P; Johansson SE; Scheltens P
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):630-5. PubMed ID: 11032615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of hippocampus volumetry using automated brain structure volumetry tool for an initial Alzheimer's disease imaging biomarker.
    Abrigo J; Shi L; Luo Y; Chen Q; Chu WCW; Mok VCT;
    Acta Radiol; 2019 Jun; 60(6):769-776. PubMed ID: 30185071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.
    Gertje EC; Pluta J; Das S; Mancuso L; Kliot D; Yushkevich P; Wolk D
    J Alzheimers Dis; 2016 Oct; 54(3):1027-1037. PubMed ID: 27567809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    Suppa P; Hampel H; Kepp T; Lange C; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2016; 51(3):867-73. PubMed ID: 26923010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of visual rating and automated brain volumetry in early detection and differential diagnosis of Alzheimer's disease.
    Mai Y; Cao Z; Zhao L; Yu Q; Xu J; Liu W; Liu B; Tang J; Luo Y; Liao W; Fang W; Ruan Y; Lei M; Mok VCT; Shi L; Liu J;
    CNS Neurosci Ther; 2024 Apr; 30(4):e14492. PubMed ID: 37864441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.